Literature DB >> 25648335

TH2 cells and their cytokines regulate formation and function of lymphatic vessels.

Kihyuk Shin1, Raghu P Kataru1, Hyeung Ju Park1, Bo-In Kwon1, Tae Woo Kim1, Young Kwon Hong2, Seung-Hyo Lee1.   

Abstract

Lymphatic vessels (LVs) are critical for immune surveillance and involved in the pathogenesis of diverse diseases. LV density is increased during inflammation; however, little is known about how the resolution of LVs is controlled in different inflammatory conditions. Here we show the negative effects of T helper type 2 (TH2) cells and their cytokines on LV formation. IL-4 and IL-13 downregulate essential transcription factors of lymphatic endothelial cells (LECs) and inhibit tube formation. Co-culture of LECs with TH2 cells also inhibits tube formation, but this effect is fully reversed by interleukin (IL)-4 and/or IL-13 neutralization. Furthermore, the in vivo blockade of IL-4 and/or IL-13 in an asthma model not only increases the density but also enhances the function of lung LVs. These results demonstrate an anti-lymphangiogenic function of TH2 cells and their cytokines, suggesting a potential usefulness of IL-4 and/or IL-13 antagonist as therapeutic agents for allergic asthma through expanding LV mediated-enhanced antigen clearance from the inflammatory sites.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25648335     DOI: 10.1038/ncomms7196

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  38 in total

Review 1.  Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung?

Authors:  Benjamin Stump; Ye Cui; Pranav Kidambi; Anthony M Lamattina; Souheil El-Chemaly
Journal:  Am J Respir Cell Mol Biol       Date:  2017-09       Impact factor: 6.914

2.  Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function.

Authors:  Epameinondas Gousopoulos; Steven T Proulx; Samia B Bachmann; Jeannette Scholl; Dimitris Dionyssiou; Efterpi Demiri; Cornelia Halin; Lothar C Dieterich; Michael Detmar
Journal:  JCI Insight       Date:  2016-10-06

3.  Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease.

Authors:  S Anand Narayanan; Corinne E Metzger; Susan A Bloomfield; David C Zawieja
Journal:  FASEB J       Date:  2018-03-29       Impact factor: 5.191

Review 4.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

5.  Interleukin-17A negatively regulates lymphangiogenesis in T helper 17 cell-mediated inflammation.

Authors:  H J Park; C M Yuk; K Shin; S-H Lee
Journal:  Mucosal Immunol       Date:  2017-09-20       Impact factor: 7.313

6.  Lymphangiogenesis in rat asthma model.

Authors:  Aigul Moldobaeva; John Jenkins; Qiong Zhong; Elizabeth M Wagner
Journal:  Angiogenesis       Date:  2016-10-27       Impact factor: 9.596

7.  Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.

Authors:  Jason C Gardenier; Geoffrey E Hespe; Raghu P Kataru; Ira L Savetsky; Jeremy S Torrisi; Gabriela D García Nores; Joseph J Dayan; David Chang; Jamie Zampell; Inés Martínez-Corral; Sagrario Ortega; Babak J Mehrara
Journal:  JCI Insight       Date:  2016-09-22

8.  IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease.

Authors:  Katia Urso; David Alvarez; Viviana Cremasco; Kelly Tsang; Angelo Grauel; Robert Lafyatis; Ulrich H von Andrian; Joerg Ermann; Antonios O Aliprantis
Journal:  JCI Insight       Date:  2016-08-04

Review 9.  New and Emerging Treatments for Lymphedema.

Authors:  Mark V Schaverien; Melissa B Aldrich
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

Review 10.  Lymphatic Dysfunction, Leukotrienes, and Lymphedema.

Authors:  Xinguo Jiang; Mark R Nicolls; Wen Tian; Stanley G Rockson
Journal:  Annu Rev Physiol       Date:  2017-10-13       Impact factor: 19.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.